What's new

Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 25, Status: Authorised

Jun 23, 2025 - 16:30
 0
Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

EMEA-003192-PIP02-23

Next Article

America’s maritime future depends on building our workforce today

Related Posts

Superseded - EMA/PDCO Summary Report on the review of t...

Jun 3, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Opdualag, nivolumab,Relatlimab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0169/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 6, 2025  0

Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Status: Opinion

Human medicines European public assessment report (EPAR...

Jun 20, 2025  0